Andrew R. Robbins, COO at ARRAY BIOPHARMA INC (ARRY), sold 50,032 shares at $17.74 ($898K) on 2018-06-27, disclosed to the SEC on 2018-06-29.
Open-market sale of $898k ARRY by COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.74 | 17,964 | $319K | 35.5% |
| 2 | $17.74 | 17,964 | $319K | 35.5% |
| 3 | $18.50 | 14,104 | $261K | 29.0% |
| Total | $17.95 avg | 50,032 | $898K | 100% |
| Filing → |